|Daily Range||$20.20 - $20.80|
|52-Week Range||$19.10 - $36.68|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||643,804|
|Current FY EPS||-$1.27|
Aegerion Pharmaceuticals, Inc. (AEGR) Description
Aegerion Pharmaceuticals, Inc. Website: http://www.aegerion.com/
Isis Pharmaceuticals has garnered a massive premium based on the potential of its antisense drug pipeline. With numerous companies entering the rare disease field, though, Isis' drugs might face stiff competition. So are investors being overly optimistic?
Earnings Reaction History: Aegerion Pharmaceuticals, Inc., 57.1% Follow-Through Indicator, 10.2% Sensitive
Isis Pharmaceuticals has had an enormous run of late. Is this drugmaker still a buy?